LERAPOLTUREV
UNII MQ5GV2WUK4

Substance Identification & Data

This profile provides standardized clinical and technical data for Lerapolturev, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MQ5GV2WUK4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2430048-02-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
MQ5GV2WUK4
CAS Registry Number
2430048-02-3
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LERAPOLTUREV
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C184921
National Cancer Institute reference terminology for clinical and research data.
INN ID
11897
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lerapolturev. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LERAPOLTUREV

Common Names & Synonyms

LERAPOLTUREV [INN]
LERAPOLTUREV [WHO-DD]
PVSRIPO (CHIMERIC POLIOVIRUS (PV), CONSISTING OF THE TYPE-1 SABIN VACCINE STRAIN CARRYING A FOREIGN INTERNAL RIBOSOME ENTRY SITE (IRES) FROM HUMAN RHINOVIRUS TYPE-2) (HRV2)
RECOMBINANT, ONCOLYTIC LIVE ATTENUATED POLIOVIRUS SABIN SEROTYPE 1 (PV1S) CONTAINING A HETEROLOGOUS INTERNAL RIBOSOMAL ENTRY SITE (IRES) FROM HUMAN RHINOVIRUS TYPE 2 (HRV2)

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus